Follow-The-Filings

Security

CRDF

Cardiff Oncology Inc. · COM

Equity holders as of 2026 Q1 (each manager’s latest book)

6 owners 2 new max 0.0% (Vanguard Group Inc.)

grid → activity →
owners 6
max % 0.0%
tracked value $13M
qoq N 2 A 2 R 1

holders

sorted by % of portfolio · long equity only

manager % port activity shares value history
Vanguard Group Inc. 2025 Q4 stale 0.0% Add 0.00 pp 3,722,085 $10M hist
Two Sigma Investments, LP 2025 Q4 stale 0.0% Exit 0.00 pp 724,957 $2M hist
Ken Griffin - Citadel Advisors LLC 2026 Q1 0.0% Add 0.00 pp 125,566 $203 hist
Renaissance Technologies LLC 2026 Q1 0.0% New 0.0% 101,253 $164 hist
Cliff Asness - Aqr Capital Management LLC 2026 Q1 0.0% New 0.0% 66,156 $107 hist
Israel Englander - Millennium Management LLC 2026 Q1 0.0% Reduce 0.00 pp 23,029 $37 hist

6 current · options excluded

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $488,000 $683,000 $593,000
Gross profit — — —
Gross margin — — —
Net income -$41.44M -$45.43M -$45.85M
Net margin * -8492.0% -6651.7% -7732.0%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $77.41M $95.05M $60.13M
Total non-current assets * $4.22M $2.14M $1.76M
Total assets $81.64M $97.19M $61.88M
Total current liabilities $10.44M $13.43M $16.39M
Total non-current liabilities * $1.46M $813,000 $102,000
Total equity $69.74M $82.95M $45.39M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$30.89M -$37.69M -$37.92M
Cash from investing $36.2M $13.73M $1.34M
Cash from financing $0.00 $53.78M $2.58M
Net change in cash $5.31M $29.82M -$34M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders